BR112017010180A2 - dispositivos e métodos para detecção de norovírus em superfícies - Google Patents

dispositivos e métodos para detecção de norovírus em superfícies

Info

Publication number
BR112017010180A2
BR112017010180A2 BR112017010180A BR112017010180A BR112017010180A2 BR 112017010180 A2 BR112017010180 A2 BR 112017010180A2 BR 112017010180 A BR112017010180 A BR 112017010180A BR 112017010180 A BR112017010180 A BR 112017010180A BR 112017010180 A2 BR112017010180 A2 BR 112017010180A2
Authority
BR
Brazil
Prior art keywords
norovirus
sample
particles
methods
detection devices
Prior art date
Application number
BR112017010180A
Other languages
English (en)
Other versions
BR112017010180B1 (pt
Inventor
He Aimin
Trong Do Bao
A Morales Cesar
William Koenig David
Hofmekler Jonathan
Huang Yang
Original Assignee
Kimberly Clark Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kimberly Clark Co filed Critical Kimberly Clark Co
Publication of BR112017010180A2 publication Critical patent/BR112017010180A2/pt
Publication of BR112017010180B1 publication Critical patent/BR112017010180B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host

Abstract

tecnologias de ensaio de fluxo lateral e fluorescência com resolução temporal fornecem uma ferramenta sensível para a detecção de partículas de norovírus em uma amostra. um dispositivo de ensaio de fluxo contínuo emprega norovírus e anticorpos g2 do norovírus. o ensaio de fluxo lateral inclui uma almofada conjugada tendo sondas conjugadas. as sondas conjugadas são partículas modificadas com um elemento de ligação que é configurado para se ligar a um norovírus. as partículas também têm um marcador fluorescente. um método geral de detectar o vírus inclui (i) preparar uma amostra com contaminantes, (ii) processar a amostra e depositá-la no dispositivo de ensaio e (iii) medir o sinal de fluorescência.
BR112017010180-7A 2014-11-27 2014-11-27 Método para detectar a presença de norovírus, e, dispositivo de ensaio de fluxo contínuo para detecção de norovírus em uma amostra BR112017010180B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2014/092404 WO2016082162A1 (en) 2014-11-27 2014-11-27 Devices and methods for detecting norovirus on surfaces

Publications (2)

Publication Number Publication Date
BR112017010180A2 true BR112017010180A2 (pt) 2018-02-06
BR112017010180B1 BR112017010180B1 (pt) 2022-10-04

Family

ID=56073364

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017010180-7A BR112017010180B1 (pt) 2014-11-27 2014-11-27 Método para detectar a presença de norovírus, e, dispositivo de ensaio de fluxo contínuo para detecção de norovírus em uma amostra

Country Status (7)

Country Link
US (1) US10209256B2 (pt)
KR (1) KR102268785B1 (pt)
AU (1) AU2014412513B2 (pt)
BR (1) BR112017010180B1 (pt)
GB (1) GB2547600B (pt)
MX (1) MX2017006287A (pt)
WO (1) WO2016082162A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190125891A (ko) 2018-04-30 2019-11-07 중앙대학교 산학협력단 노로바이러스 검출용 펩타이드 및 이를 이용한 검출방법
KR102347135B1 (ko) * 2020-03-19 2022-01-05 프리시젼바이오 주식회사 시분해 형광분석을 이용한 노로바이러스 측방 유동 분석장치 및 이를 이용한 측정방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT54896A (en) 1989-03-17 1991-04-29 Chiron Corp Process for producing aquous diagnosticum and vaccine of nanbv
US6153378A (en) 1992-10-16 2000-11-28 Bionova Corporation Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus
US6153392A (en) 1997-07-30 2000-11-28 Bionova Corporation Devices and methods comprising an HBcAg from hepatitis B virus
EP1801591B1 (en) 1997-08-04 2016-12-28 Advanced Life Science Institute, Inc. Methods for detection or measurement of viruses
US7285424B2 (en) * 2002-08-27 2007-10-23 Kimberly-Clark Worldwide, Inc. Membrane-based assay devices
EP1532449B1 (en) * 2002-08-27 2010-05-12 Kimberly-Clark Worldwide, Inc. Membrane-based assays using time-resolved fluorescence
US20060003957A1 (en) 2004-05-05 2006-01-05 Washington University In St. Louis RNA virus expression and replication, methods and uses therefor
WO2006098752A2 (en) 2004-07-29 2006-09-21 Kim Laboratories Ultrasensitive sensor and rapid detection of analytes
WO2007118209A2 (en) 2006-04-07 2007-10-18 Kim Laboratories Apparatus and method for rapid detection of analytes
CN101187665B (zh) 2007-12-27 2011-08-10 北京博晖创新光电技术股份有限公司 一种肠道病毒的免疫荧光层析检测试纸及其制备方法
US10369204B2 (en) 2008-10-02 2019-08-06 Dako Denmark A/S Molecular vaccines for infectious disease
CN101497928B (zh) 2009-01-07 2012-04-18 珠海国际旅行卫生保健中心 鉴定ggⅰ组诺如病毒和ggⅱ组诺如病毒的方法及专用试剂盒
KR20120109476A (ko) 2009-09-28 2012-10-08 킴 래버러터리즈, 아이엔씨. 감염성 노로바이러스를 소독하기 위한 화학적, 생물학적 및 물리학적 제제의 스크리닝 방법
CN102154528B (zh) 2011-05-20 2013-01-09 何雅青 轮状病毒和诺如病毒液相芯片检测用引物、探针及试剂盒
MX349562B (es) 2011-12-09 2017-08-02 Pasteur Institut Ensayo de inmuno deteccion multiplex.
CN203759021U (zh) * 2013-11-08 2014-08-06 北京易斯威特生物医学科技有限公司 诺如病毒检测试剂盒

Also Published As

Publication number Publication date
KR20170086060A (ko) 2017-07-25
KR102268785B1 (ko) 2021-06-25
US20170322212A1 (en) 2017-11-09
MX2017006287A (es) 2017-08-14
US10209256B2 (en) 2019-02-19
GB2547600A (en) 2017-08-23
WO2016082162A1 (en) 2016-06-02
AU2014412513A1 (en) 2017-06-15
AU2014412513B2 (en) 2021-04-08
GB2547600B (en) 2021-02-10
BR112017010180B1 (pt) 2022-10-04
GB201709015D0 (en) 2017-07-19

Similar Documents

Publication Publication Date Title
MX366275B (es) Metodos para detectar y medir la agregacion.
MX2020009021A (es) Ensayos para detectar la presencia o la cantidad de un anticuerpo antifarmaco.
MX2019015016A (es) Ensayos para la deteccion de una sola molecula y uso de los mismos.
BR112017011932A8 (pt) Anticorpos direcionados a receptor acoplado a proteína g e métodos de uso
BR112014025384A8 (pt) método e sistema para executar ensaio automatizado e métodos para executar teste reflexivo em vários exemplares
BR112017009151A2 (pt) ensaios para detectar subgrupos imunológicos de célula t e métodos de uso dos mesmos
BR112016028944A2 (pt) kit ou dispositivo para a detecção de câncer do trato biliar e método de detecção
EA201590027A1 (ru) Способы детекции заболеваний или состояний
TR201904386T4 (tr) Nükleotidleri içeren nükleozomların saptanmasına yönelik yöntem.
CO6680668A2 (es) Ensayos biomarcadores para detectar o medir inhibición de actividad quinasa tor
BR112016029521A2 (pt) ?kit, dispositivo e método para a detecção de câncer de estômago?
BR112014012590A8 (pt) Anticorpos anti-cd98 e métodos de uso dos mesmos
IN2015DN01876A (pt)
BR112017021686A2 (pt) método para detectar uma ou várias carbapenemases, dispositivo para detectar imunocromatográfico e uso do dispositivo para detectar imunocromatográfico
BR112016010106A2 (pt) ensaios para igfbp7 com melhor desempenho em amostras biológicas
BR112016002685A2 (pt) ensaios para timp2 que apresentam melhor desempenho em amostras biológicas
BR112016022829A8 (pt) Dispositivo de teste para determinar a presença de um primeiro ligante em uma amostra líquida e método para testar uma amostra quanto à presença de um primeiro ligante
GB2528657A8 (en) Sample analysing device
IT201600073964A1 (it) Nanointerruttore basato su nucleotidi e metodi per la rilevazione di anticorpi e altri analiti
MX2017007232A (es) Ensayos de desplazamiento por movilidad homogeneos indirectos para la deteccion de productos biologicos en muestras de pacientes.
CY1123180T1 (el) Συστημα ανιχνευσης που αξιοποιει αλυσιδωτη αντιδραση πολυμερασης
EA201991506A1 (ru) Системы и способы для тестирования и скрининга с использованием связанных с соединениями субстратов
EA201500377A1 (ru) Способ обнаружения анализируемого вещества и определение его концентрации с использованием намагничиваемых гранул
SG10201806729VA (en) Novel assay to detect human periostin
BR112016003058A2 (pt) composições e métodos para análise multiplex de ácidos nucleicos nras e braf

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/11/2014, OBSERVADAS AS CONDICOES LEGAIS